Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine
Are we ready to use minimal residual disease (MRD) to direct multiple myeloma therapy?
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Bettering the outcomes of transplant with the French biobank project
Regis Peffault de Latour
Defibrotide to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome in AML & ALL